Jane Spetzler
14Patents
6h-index
32Co-inventors
62Inventor score
Filing activity: Sep 24, 2001 → Nov 22, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6875741B2 | Insulin and IGF-1 receptor agonists and antagonists | Chemistry; Metallurgy | 36 | Expired |
| US8895694B2 | Glucagon-Like Peptide-1 derivatives and their pharmaceutical use | Human Necessities | 24 | Active |
| US10005827B2 | Double-acylated GLP-1 derivatives | Human Necessities | 22 | Active |
| US8815802B2 | GLP-1 analogues and derivatives | Physics | 18 | Active |
| US9067977B2 | Peptides derivatized with A-B-C-D- and their therapeutical use | Human Necessities | 16 | Active |
| US9708383B2 | Double-acylated GLP-1 derivatives | Human Necessities | 10 | Active |
| US11117947B2 | Double-acylated GLP-1 derivatives | Human Necessities | 5 | Active |
| US9409966B2 | Glucagon-like peptide-1 derivatives and their pharmaceutical use | Human Necessities | 4 | Active |
| US11034746B2 | Double-acylated GLP-1 derivatives | Human Necessities | 4 | Active |
| US9012398B2 | Acylated exendin-4 compounds | Human Necessities | 4 | Active |
| US9260503B2 | Multi-substituted insulins | Chemistry; Metallurgy | 3 | Active |
| US9657079B2 | Truncated GLP-1 derivatives and their therapeutical use | Human Necessities | 2 | Active |
| US9556250B2 | Double-acylated GLP-1 derivatives | Physics | 2 | Active |
| US9988430B2 | Stable GLP-1 based GLP-1/glucagon receptor co-agonists | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.